Dementia Mental and Behavioural Disorders
Conditions
Interventions
This study explores whether a structured, scalable approach, using trained Health Care Assistants (HCAs) to administer cognitive test bundles tailored to patient presentation, can support GPs in makin
Sponsors
University of Bristol
Eligibility
Sex/Gender
All
Age
75 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1. Be aged 75 years or older 2. Present with cognitive symptoms for at least 6 months 3. Not have a prior diagnosis of dementia 4. Have a supporter they have known for several years who is prepared to complete informant and functionality questionnaires
Exclusion criteria
Exclusion criteria: 1. Sensory impairment (registered blind or unable to use a phone due to deafness) 2. Learning disability 3. No availability of a supporter (e.g. family member or friend) who knows them well and is willing to complete informant and functional questionnaires. Supporters may provide input remotely if needed 4. Presence of other neurological conditions (e.g. Parkinson’s disease) that would typically require specialist assessment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Recruitment rate of eligible patients in each practice measured using recruitment records at the end of the study 2. % of outcome measures (General Anxiety Inventory, EQ5D-5L, ICECAP-O items) collected at baseline and follow up in each practice measured using data records at the end of the study | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Acceptability of the intervention to patients, supporters, and healthcare professionals is measured using semi-structured interviews and observations at end of study 2. GP confidence in assessing dementia is measured using pre- and post-training surveys at baseline and immediately post-training 3. HCA confidence in assessing dementia is measured using pre- and post-training surveys at baseline and immediately post-training 4. Fidelity to the study protocol is measured using observations of assessment delivery and documentation of deviations with rationale at end of study 5. Diagnostic robustness is measured using expert clinical review of selected cases to assess appropriateness and quality of diagnoses at end of study 6. Long-term outcomes including onward referrals and confirmed diagnoses are measured using GP records at baseline and annually for seven years 7. Recruitment reach and representation for underserved NHS populations is measured using screening logs at end of study 8. Reasons for non-participation are measured using screening logs and optional brief interviews with a small number of patients and supporters who decline participation at end of study | — |
Countries
England, United Kingdom
Contacts
Public ContactSam Creavin
Outcome results
None listed